World health organisation experts have issued another recommendation for the use of the Sinopharm vaccine to fight against COVID-19. Since the supply of vaccines is limited, the health worker is at high risk of exposure. The Sinopharm vaccine is not recommended for persons under the age of 18.
How about pregnant women?
No enough evidence shows whether pregnant women should use the vaccine or not. However, the vaccine is an inactive vaccine that has been used to produce other vaccines with safety profiles, including in pregnant women. The effectiveness of Sinopharm in pregnant women is expected to be positive.
According to WHO, the use of the COVID-19 vaccine in pregnant women outweighs the benefits as compared to potential risks. In this case, pregnant women should make the assessment, they should be given information about the risks of COVID-19 in pregnancy. However, the organisation does not provide any pregnancy testing before vaccination.
Who else can take the vaccine?
The vaccine can be given to people with past COVID-19 experience. Within 6 months after the initial natural infection, the data available shows that symptomatic reinfection is not usual. With a limited supply of vaccines, individuals with previous COVID-19 infection may choose to delay the vaccination until near the end of 6 months.
Lactating mothers can also take the vaccine because its effectiveness is the same as in other adults. According to WHO, lactating mothers should not stop breastfeeding after vaccination.
Individuals living with the Human immunodeficiency virus (HIV) are at higher risk of being infected with COVID-19 disease. These individuals are not included in the trial but given this as a non-replicating vaccine, therefore, people with HIV are recommended group for vaccination but information and Counseling should be provided where necessary about the benefit-risk of assessment.
Vaccine not recommended to?
- People with previous anaphylaxis diagnosis
- Anyone with a body temperature over 38.5 degrees